HilleVax, Inc. (HLVX)

NASDAQ: HLVX · IEX Real-Time Price · USD
15.62
-0.22 (-1.39%)
Mar 27, 2024, 4:00 PM EDT - Market closed

Total Valuation

HilleVax has a market cap or net worth of $787.26 million. The enterprise value is $533.34 million.

Market Cap 787.26M
Enterprise Value 533.34M

Important Dates

The last earnings date was Wednesday, March 20, 2024, after market close.

Earnings Date Mar 20, 2024
Ex-Dividend Date n/a

Share Statistics

HilleVax has 49.70 million shares outstanding. The number of shares has increased by 49.55% in one year.

Shares Outstanding 49.70M
Shares Change (YoY) +49.55%
Shares Change (QoQ) +22.02%
Owned by Insiders (%) 7.45%
Owned by Institutions (%) 76.43%
Float 22.18M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 2.96
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.62, with a Debt / Equity ratio of 0.19.

Current Ratio 10.62
Quick Ratio n/a
Debt / Equity 0.19
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -50.66

Financial Efficiency

Return on equity (ROE) is -48.20% and return on invested capital (ROIC) is -42.10%.

Return on Equity (ROE) -48.20%
Return on Assets (ROA) -38.10%
Return on Capital (ROIC) -42.10%
Revenue Per Employee n/a
Profits Per Employee -$1.37M
Employee Count 90
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +0.84% in the last 52 weeks.

Beta (1Y) n/a
52-Week Price Change +0.84%
50-Day Moving Average 16.17
200-Day Moving Average 14.60
Relative Strength Index (RSI) 39.51
Average Volume (30 Days) 125,513

Short Selling Information

The latest short interest is 474,856, so 0.96% of the outstanding shares have been sold short.

Short Interest 474,856
Short Previous Month 431,019
Short % of Shares Out 0.96%
Short % of Float 2.14%
Short Ratio (days to cover) 2.58

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -133.35M
Pretax Income -123.57M
Net Income -123.57M
EBITDA -119.02M
EBIT -121.17M
Earnings Per Share (EPS) -$3.04
Full Income Statement

Balance Sheet

The company has $305.11 million in cash and $51.19 million in debt, giving a net cash position of $253.92 million or $5.11 per share.

Cash & Cash Equivalents 305.11M
Total Debt 51.19M
Net Cash 253.92M
Net Cash Per Share $5.11
Equity / Book Value 265.53M
Book Value Per Share 5.34
Working Capital 281.41M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$86.78 million and capital expenditures -$10.75 million, giving a free cash flow of -$97.53 million.

Operating Cash Flow -86.78M
Capital Expenditures -10.75M
Free Cash Flow -97.53M
FCF Per Share -$2.40
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

HilleVax does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -49.55%
Shareholder Yield -49.55%
Earnings Yield -15.70%
FCF Yield -12.39%

Analyst Forecast

The average price target for HilleVax is $28.50, which is 82.46% higher than the current price. The consensus rating is "Strong Buy".

Price Target $28.50
Price Target Difference 82.46%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -25.08%
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1